Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

EU flag

EMA transparency policy delayed over ‘wording’

Regulation on access to trial data postponed until October

Samsung incentivises African mHealth project with music

Will also offer discounted handsets and tablets to consumers and health workers

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

Pharma’s shrinking waterhole

A natural metaphor makes us think about our strategy

- PMLiVE

UDG buys Galliard and Nyxeon

Will add UK comms firms to Ashfield Healthcare Communications division

Baxter reshuffles financial heads

Names CFOs for biotech spin-off and 'new' Baxter

- PMLiVE

Illumina to provide sequencing for UK gene project

Genomics England wants company to sequence genomes of 100,000 NHS patients

- PMLiVE

EU hits Servier and generic firms with €428m ‘pay-for-delay’ fine

Follows deals to delay competition for blood pressure drug Coversyl/Aceon

Novartis building

Novartis’ secukinumab tops Enbrel in psoriasis

Data reinforces secukinumab's position among new generation of biologic

France flag

Pharma criticises France’s backing for off-label Avastin use

EFPIA weighs in on proposal to move wet AMD patients to the drug as a cheaper alternative

- PMLiVE

Mars appoints chief health officer

Debra Sandler assumes newly-created role

- PMLiVE

Drug apps should be reviewed by pharmacists

EAHP advises that any app linked to the use of medicines must have regulatory oversight to ensure safety

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links